Bank of New York Mellon Corp
BankPosition in ACRS — Aclaris Therapeutics, Inc.
CIK 1390777
NEW YORK, NY
Position in ACRS
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$776,339
+$163,754 QoQ
Shares Held
207,024
+1.7% QoQ
Ownership
0.148%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 86.89282402040344.ToString("F0")%
Shared 0.ToString("F0")%
None 13.107175979596569.ToString("F0")%
Common Shares in ACRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $4,203,063,863 across 270 Biotechnology names. ACRS ranks #185 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,586,427 | $708,403,098 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
765,411 | $591,387,145 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,679,371 | $317,485,079 | |
| 4 | INSM |
INSMED Inc
|
1,262,749 | $206,484,708 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
491,200 | $162,523,337 | |
| 6 | INCY |
Incyte Corp
|
989,709 | $93,151,403 | |
| 7 | TECH |
BIO-TECHNE Corp
|
1,759,119 | $91,931,549 | |
| 8 | MRNA |
Moderna, Inc.
|
1,691,205 | $85,913,207 |
All Filings in ACRS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $776,339 | 207,024 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $612,585 | 203,517 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $418,154 | 220,082 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $305,671 | 215,262 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $20,766 | 13,573 | Shares | Defined | 2025-04-29 | |
| 2024-03-31 | $288,635 | 232,771 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $296,489 | 282,371 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $1,662,973 | 242,770 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $2,513,956 | 242,426 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $1,862,882 | 230,270 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $3,647,903 | 231,613 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,681,301 | 233,882 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,822,696 | 202,199 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,199,674 | 185,596 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $2,709,121 | 186,322 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $3,280,410 | 182,245 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $2,374,849 | 135,242 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $2,801,130 | 111,156 | Shares | Other | 2021-05-13 | |
| 2020-09-30 | $280,676 | 109,213 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $176,924 | 109,213 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $226,492 | 217,783 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||